Certolizumab Pegol Efficacy Across Methotrexate Regimens: A Pre‐Specified Analysis of Two Phase III Trials

OBJECTIVE: Anti–tumor necrosis factor (anti‐TNF) agents are frequently used in combination with methotrexate (MTX) to treat rheumatoid arthritis (RA). We investigated the effect of a background MTX dose, in combination with anti‐TNF certolizumab pegol (CZP), on treatment efficacy and safety in RA pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Combe, Bernard, Furst, Daniel E., Keystone, Edward C., van der Heijde, Désirée, Luijtens, Kristel, Ionescu, Lucian, Goel, Niti, Emery, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067694/
https://www.ncbi.nlm.nih.gov/pubmed/26238672
http://dx.doi.org/10.1002/acr.22676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067694/
https://www.ncbi.nlm.nih.gov/pubmed/26238672
http://dx.doi.org/10.1002/acr.22676

Ejemplares similares